Lilly and Novo Start Measuring Whether GLP-1s Extend Life

AstraZeneca, Novartis, Novo (formally Novo Nordisk) and Eli Lilly all spoke from the platform at this year's ARDD at Harvard. Novo and Lilly each showed...